BioSpace News Archive

A well-known market intelligence company, Infiniti Research, has partnered with several global companies across industries to help meet their strategic objectives and implement seamless route-to-market strategies through turnkey solutions.

The American Association of Nurse Practitioners®, representing the interests of America’s 290,000 nurse practitioners, welcomes actions taken by the governors of Kentucky, Louisiana, New Jersey, New York and Wisconsin to suspend state regulatory barriers that limit NPs from combatting the growing COVID-19 crisis.

A group of doctors and engineers from UC San Francisco, UC Berkeley and other hospitals and businesses today announced that they have developed a simple technique for repurposing sleep apnea machines so they can be used as ventilators as demand outstrips supply for the life-saving devices in hospitals overwhelmed by COVID-19 patients.

Hawkeye Systems, Inc., a technology holding company now focused on pandemic management products and services, announced it has begun fulfilling its first $1.25M purchase order from the City of Memphis to support its critical need for 3-ply respirator masks.

CytoSorbents Corporation (NASDAQ: CTSO) a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically-ill and cardiac surgery patients around the world, announced that its Chief Executive Officer, Dr. Phillip Chan, MD, PhD will participate in a conference call,

Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems has announced the completion of its recent article that examines the role of pharma analytics in enhancing clinical trial outcomes amidst the major outbreak of COVID-19.

The U.S. Food and Drug Administration continues to play a critical role in accelerating medical countermeasures to treat and prevent COVID-19

Medical Devices & Diagnostics (MD&D) companies know they are being impacted by the current pandemic and are seeking independent research to quantify how much their markets will decline or increase, how long the recovery will take, and what factors will determine that recovery.

A case study of a patient in Wuhan, China, suggests that the immunosuppressant tocilizumab may be an effective COVID-19 treatment for very ill patients who also have multiple myeloma and other blood cancers

The Montreal Heart Institute Foundation is proud to announce that philanthropist Sophie Desmarais will be supporting the Montreal Heart Institute’s research projects thanks to a $1 million donation that will be used by the Research Centre for their ColCorona study.